If you look at all the positive news in Just the past eight weeks: satisfaction of 2016 convo note, control of the parents, journal of surgical oncology, special protocol agreement with FDA, 500th chemosat treatment in Europe and most recently the commercial supply agreement . Wrap all that up with improved financials in q3 and hopefully continued for q4. Now remove the billion share /rs proposal from the equation and where should the share price really be sitting. Also add the possibility of a large stake in the company by another entity yet unknown. This vote is not about an RS or mass dilution....it is a vote to keep management or let nature take its course. This is of course just my opinion. I am a DCTH shareholder so obviously a flawed thinker !!!